3 news items
ProKidney Announces Positive Interim REGEN-007 Phase 2 Trial Data and Provides Clinical and Operational Updates
PROK
10 Jun 24
in patients with moderate to severe CKD, the potential QP Declaration of Equivalence to EU GMPs, the potential benefits and impact of the Company's products
ProKidney to Host Virtual KOL Event to Discuss Current Treatment Landscape of Chronic Kidney Disease Caused by Diabetes and Data from Phase 2 RMCL-002 Clinical Trial on May 28, 2024
PROK
21 May 24
, if approved, the potential benefits and impact of the Company's products, if approved, potential regulatory approvals, the size and potential growth
ProKidney Reports Business Updates and First Quarter 2024 Financial Results
PROK
10 May 24
, the potential benefits and impact of the Company's products, if approved, potential regulatory approvals, the size and potential growth of current
- Prev
- 1
- Next